PubMed ID:
31296647
Public Release Type:
Journal
Publication Year: 2019
Affiliation: Division of Environmental Health Sciences, School of Public Health, University of California, Berkeley, Berkeley, CA andres.cardenas@berkeley.edu.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA.; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA.; Department of Biostatistics and Epidemiology, University of Massachusetts-Amherst School of Public Health and Health Sciences, Amherst, MA.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.; Division of Pediatric Endocrinology and Diabetes, Maine Medical Center, Portland, ME.; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.; Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.; Department of Environmental Health, Boston University School of Public Health, Boston, MA.; Joslin Diabetes Center, Harvard Medical School, Boston, MA.; Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
DOI:
https://doi.org/10.2337/dc18-2254
Authors:
Cardenas Andres, Hivert Marie-France, Gold Diane R, Hauser Russ, Kleinman Ken P, Lin Pi-I D, Fleisch Abby F, Calafat Antonia M, Ye Xiaoyun, Webster Thomas F, Horton Edward S, Oken Emily
Request IDs:
20499
,
21291
Studies:
Diabetes Prevention Program Outcomes Study
Perfluoroalkyl and polyfluoroalkyl substances (PFASs) are suspected endocrine disruptors widely detected across populations. We examine the extent to which PFASs are associated with diabetes incidence and microvascular disease. Secondarily, we tested whether a lifestyle intervention modifies associations and decreases concentrations.